Skip to main content

Advertisement

Log in

Biochemical, Pharmacological and Structural Characterization of a New PLA2 from Crotalus durissus terrificus (South American Rattlesnake) Venom

  • Published:
The Protein Journal Aims and scope Submit manuscript

Abstract

A new PLA2 (F16) was purified from Crotalus durissus terrificus venom by molecular exclusion chromatography followed by analytical reverse phase HPLC. The PLA2 (14.86 kDa by MALDI-TOF mass spectrometry) had an amino acid sequence of SLLQFNKMIKFETRKNAVPFYAFYGCYCGWGGRRRPKDATDRCCFVHDCCYEKVTKCNTKWDIYRYSLKSGYITCGKGTWCKEQICECDRVAAECLRRSLSTYKNGYMFYPDSRCRGPSETC, and showed highly conserved Ca2+-binding and catalytic sites. F16 showed allosteric behavior with 10 mM Ca2+ and had temperature and pH optima of 25°C and 7.9, respectively. F16 (10 μg/ml) produced neuromuscular blockade in chick biventer cervicis preparations in the absence and presence of crotapotin, indicating that crotapotin was not essential for neuromuscular action in this preparation. In contrast, in mouse phrenic nerve-diaphragm preparations, the neuromuscular blockade produced by the same concentration of toxin was dependent on crotapotin. Pre-incubation with heparin markedly reduced the neurotoxicity of F16. These results show that the biochemical and structural properties of F16 are similar to those of the PLA2 isoforms F15 and F17, but that the neurotoxicity and the requirement for crotapotin to form the crotoxin complex varies according to the neuromuscular preparation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

Clt:

clostripain

CNBr:

cyanogen bromide

DTT:

dithiothreitol

MALDI-TOF:

matrix-assisted laser desorption/ionization time-of-flight

RC:

reduced and carboxymethylated

RP-HPLC:

reversed-phase high performance liquid chromatography

SV8:

Staphylococcus aureus protease V8

TFA:

trifluoroacetic acid.

References

  • F. A. A. Araújo M. SantaLúcia R. F. Cabral (2003) Epidemioligia dos Acidentes por Animais Peçonhentos. J. L. C. Cardoso F. O. S. França H. W. Fan C. M. S. Málaque V. Haddad SuffixJr. (Eds) Animais Peçonhentos no Brasil. Biologia, Clínica e Terapêutica dos Acidentes Sarvier/FAPESP São Paulo 6–12

    Google Scholar 

  • M. M. Azevedo-Marques S. E. Hering P. Cupo (2003) Acidente Crotálico. J. L. C. Cardoso F. O. S. França H. W. Fan C. M. S. Málaque V. Haddad SuffixJr. (Eds) Animais Peçonhentos no Brasil. Biologia, Clínica e Terapêutica dos Acidentes Sarvier/FAPESP São Paulo 91–98

    Google Scholar 

  • D. G. Beghini S. Hernandez-Oliveira L. Rodrigues-Simioni J. C. Novello S. Hyslop S. Marangoni (2004a) Toxicon 44 141–148 Occurrence Handle10.1016/j.toxicon.2004.05.011

    Article  Google Scholar 

  • D. G. Beghini L. Rodrigues-Simioni M. H. Toyama J. C. Novello M. A. da Cruz-Höfling S. Marangoni (2004b) Toxicon 43 255–261 Occurrence Handle10.1016/j.toxicon.2003.12.001

    Article  Google Scholar 

  • D. G. Beghini M. H. Toyama S. Hyslop L. Sodek J. C. Novello S. Marangoni (2000) J. Protein Chem. 19 603–607 Occurrence Handle10.1023/A:1007123329817 Occurrence Handle11233174

    Article  PubMed  Google Scholar 

  • C. Bon C. Bouchier V. Choumet G. Faure M. S. Jiang M. P. Lambezat F. Radvanyi B. Saliou (1989) Acta Physiol. Pharmacol. Latinoam. 39 439–448 Occurrence Handle2562459

    PubMed  Google Scholar 

  • J. V. Bonventre A. Sapirstein (2002) Adv. Exp. Med. Biol. 507 25–31 Occurrence Handle12664560

    PubMed  Google Scholar 

  • E. Bülbring (1946) Br. J. Pharmacol. 1 38–61

    Google Scholar 

  • V. Choumet C. Bouchier E. Delot G. Faure B. Saliou C. Bon (1996) Adv. Exp. Med. Biol. 391 197–202 Occurrence Handle8726057

    PubMed  Google Scholar 

  • E. A. Dennis (1994) J. Biol. Chem. 269 13057–13060 Occurrence Handle8175726

    PubMed  Google Scholar 

  • G. Faure C. Bon (1987) Toxicon 25 229–234 Occurrence Handle10.1016/0041-0101(87)90246-7 Occurrence Handle3576640

    Article  PubMed  Google Scholar 

  • G. Faure C. Bon (1988) Biochemistry 27 730–738 Occurrence Handle10.1021/bi00402a036 Occurrence Handle3349062

    Article  PubMed  Google Scholar 

  • G. Faure V. Choumet C. Bouchier L. Camoin J. L. Guillaume B. Monegier M. Vuilhorgne C. Bon (1994) Eur. J. Biochem. 223 161–164 Occurrence Handle10.1111/j.1432-1033.1994.tb18978.x Occurrence Handle8033889

    Article  PubMed  Google Scholar 

  • G. Faure J. L. Guillaume L. Camoin B. Saliou C. Bon (1991) Biochemistry 30 8074–8083 Occurrence Handle10.1021/bi00246a028 Occurrence Handle1868083

    Article  PubMed  Google Scholar 

  • G. Faure A. L. Harvey E. Thomson B. Saliou F. Radvanyi C. Bon (1993) Eur. J. Biochem. 214 491–496 Occurrence Handle10.1111/j.1432-1033.1993.tb17946.x Occurrence Handle8513799

    Article  PubMed  Google Scholar 

  • B. L. Ginsborg J. Warriner (1960) Br. J. Pharmacol. 15 410–421

    Google Scholar 

  • J. M. Gutiérrez B. Lomonte (1995) Toxicon 33 1405–1424 Occurrence Handle10.1016/0041-0101(95)00085-Z Occurrence Handle8744981

    Article  PubMed  Google Scholar 

  • J. M. Gutiérrez C. L. Ownby (2003) Toxicon 42 915–931 Occurrence Handle10.1016/j.toxicon.2003.11.005 Occurrence Handle15019491

    Article  PubMed  Google Scholar 

  • E. Habermann H. Breithaupt (1978) Toxicon 16 19–30 Occurrence Handle10.1016/0041-0101(78)90056-9 Occurrence Handle622722

    Article  PubMed  Google Scholar 

  • R. A. Hendon H. Fraenkel-Conrat (1971) Proc. Natl. Acad. Sci. USA 68 1560–1563 Occurrence Handle5283946

    PubMed  Google Scholar 

  • M. Holzer S. P. Mackessy (1996) Toxicon 34 1149–1155 Occurrence Handle10.1016/0041-0101(96)00057-8 Occurrence Handle8931255

    Article  PubMed  Google Scholar 

  • R. M. Kini (2003) Toxicon 42 827–840 Occurrence Handle10.1016/j.toxicon.2003.11.002 Occurrence Handle15019485

    Article  PubMed  Google Scholar 

  • R. M. Kini H. J. Evans (1989) Toxicon 7 613–635 Occurrence Handle10.1016/0041-0101(89)90013-5

    Article  Google Scholar 

  • I. Kudo M. Murakami (2002) Prostag. Oth. Lipid Mediat. 68 3–58 Occurrence Handle10.1016/S0090-6980(02)00020-5

    Article  Google Scholar 

  • G. Lambeau M. Lazdunski (1999) Trends Pharmacol. Sci. 20 162–170 Occurrence Handle10.1016/S0165-6147(99)01300-0 Occurrence Handle10322502

    Article  PubMed  Google Scholar 

  • B. W. Lennon I. I. Kaiser (1990) Comp. Biochem. Physiol. B 97 695–699 Occurrence Handle10.1016/0305-0491(90)90109-7 Occurrence Handle2085953

    Article  PubMed  Google Scholar 

  • B. Lomonte Y. Angulo L. Calderón (2003) Toxicon 42 885–901 Occurrence Handle10.1016/j.toxicon.2003.11.008 Occurrence Handle15019489

    Article  PubMed  Google Scholar 

  • R. J. Mayer L. A. Marshall (1993) FASEB J. 7 339–348 Occurrence Handle8440410

    PubMed  Google Scholar 

  • D. G. Oliveira M. H. Toyama J. C. Novello L. O. Beriam S. Marangoni (2002) J. Protein Chem. 21 161–168 Occurrence Handle10.1023/A:1015320616206 Occurrence Handle12018617

    Article  PubMed  Google Scholar 

  • L. A. Ponce-Soto M. H. Toyama S. Hyslop J. C. Novello S. Marangoni (2002) J. Protein Chem. 21 131–136 Occurrence Handle10.1023/A:1015332314389 Occurrence Handle12018613

    Article  PubMed  Google Scholar 

  • A. Rangel-Santos E. C. Dos-Santos M. Lopes-Ferreira C. Lima D. F. Cardoso I. Mota (2004) Toxicon 43 801–810 Occurrence Handle10.1016/j.toxicon.2004.03.011 Occurrence Handle15284014

    Article  PubMed  Google Scholar 

  • H. Selistre-de-Araujo S. P. White C. L. Ownby (1996) Arch. Biochem. Biophys. 326 21–30 Occurrence Handle10.1006/abbi.1996.0042 Occurrence Handle8579368

    Article  PubMed  Google Scholar 

  • A. M. Soares J. R. Giglio (2003) Toxicon 42 855–868 Occurrence Handle10.1016/j.toxicon.2003.11.004 Occurrence Handle15019487

    Article  PubMed  Google Scholar 

  • M. H. Toyama D. G. Oliveira L. O. S. Beriam J. C. Novello L. Rodrigues-Simioni S. Marangoni (2003) Toxicon 41 1033–1045 Occurrence Handle10.1016/S0041-0101(03)00085-0 Occurrence Handle12875878

    Article  PubMed  Google Scholar 

  • M. H. Toyama A. M. Soares C. A. Vieira J. C. Novello B. Oliveira J. R. Giglio S. Marangoni (1998) J. Protein Chem. 17 713–718 Occurrence Handle9853687

    PubMed  Google Scholar 

  • M. H. Toyama A. M. Soares L. Wen-Hwa I. Polikarpov J. R. Giglio S. Marangoni (2000) Biochimie 82 245–250 Occurrence Handle10.1016/S0300-9084(00)00202-9 Occurrence Handle10863008

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Léa Rodrigues-Simioni.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hernandez-Oliveira, S., Toyama, M.H., Toyama, D.O. et al. Biochemical, Pharmacological and Structural Characterization of a New PLA2 from Crotalus durissus terrificus (South American Rattlesnake) Venom. Protein J 24, 233–242 (2005). https://doi.org/10.1007/s10930-005-6718-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10930-005-6718-z

Key words

Navigation